116 related articles for article (PubMed ID: 29730911)
1. [Prognostic factors analysis of Ki-67, α-SMA expression in retroperitoneal leiomyosarcoma].
Ma C; Li PY; Zhang N; Sun CB; Hou L; Liu N
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):258-263. PubMed ID: 29730911
[No Abstract] [Full Text] [Related]
2. [Expression of CD133 in primary retroperitoneal leiomyosarcoma and its relationship with Ki-67].
She Y; Liang J; Qiu Y; Liu N; Huang X; Zhao X; Li P
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(16):1241-4. PubMed ID: 24924889
[TBL] [Abstract][Full Text] [Related]
3. CREPT expression correlates with poor prognosis in patients with retroperitoneal leiomyosarcoma.
She Y; Liang J; Chen L; Qiu Y; Liu N; Zhao X; Huang X; Wang Y; Ren F; Chang Z; Li P
Int J Clin Exp Pathol; 2014; 7(10):6596-605. PubMed ID: 25400738
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in patients with recurrent or metastatic retroperitoneal leiomyosarcoma.
Li Q; Zhuang R; Zhu J; Lu W; Hou Y; Liu J; Zhang Y; Wang Y; Liu T; Wang Z; Zhou Y
Future Oncol; 2015; 11(12):1759-66. PubMed ID: 26075444
[TBL] [Abstract][Full Text] [Related]
5. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
Tseng W; Martinez SR; Tamurian RM; Borys D; Canter RJ
J Surg Res; 2012 Jan; 172(1):123-30. PubMed ID: 20869082
[TBL] [Abstract][Full Text] [Related]
6. Extended resection including adjacent organs and Ki-67 labeling index are prognostic factors in patients with retroperitoneal soft tissue sarcomas.
Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
World J Surg Oncol; 2016 Feb; 14(1):43. PubMed ID: 26911364
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic factors predicting postoperative survival period in the treatment of primary retroperitoneal leiomyosarcoma].
Zhao XD; Li PY; Huang XH; Chen L; Li R; Liu N
Zhonghua Wai Ke Za Zhi; 2013 Oct; 51(10):891-4. PubMed ID: 24433766
[TBL] [Abstract][Full Text] [Related]
8. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
9. [Predictors of local recurrence and survival in primary retroperitoneal leiomyosarcoma].
Chen G; Yan Y; Xiao C; Sun P; Xue H; Li R
Zhonghua Wai Ke Za Zhi; 2014 Feb; 52(2):105-8. PubMed ID: 24809517
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.
Shpitz B; Tiomkin V; Bomstein Y; Gralkin M; Buklan H; Bernheim J; Klein E
Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760
[TBL] [Abstract][Full Text] [Related]
11. Leiomyosarcoma in soft tissue: examination of p53 status and cell proliferating factors in different locations.
Konomoto T; Fukuda T; Hayashi K; Kumazawa J; Tsuneyoshi M
Hum Pathol; 1998 Jan; 29(1):74-81. PubMed ID: 9445137
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of PRUNE2 in leiomyosarcoma.
Zhao LR; Tian W; Wang GW; Chen KX; Yang JL
Chin J Cancer; 2013 Dec; 32(12):648-52. PubMed ID: 23731771
[TBL] [Abstract][Full Text] [Related]
13. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
Amada S; Nakano H; Tsuneyoshi M
Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in retroperitoneal sarcomas: ploidy of DNA as a predictor of clinical outcome.
Herman K; Gruchała A; Niezabitowski A; Gliński B; Lackowska B
J Surg Oncol; 1999 May; 71(1):32-5. PubMed ID: 10362089
[TBL] [Abstract][Full Text] [Related]
15. Leiomyosarcoma: investigation of prognostic factors for risk-stratification model.
Kim HJ; Cho YJ; Kim SH; Rha SY; Ahn JB; Yang WI; Lee YH; Suh JS; Roh JK; Kim KS; Choi YD; Shin KH; Kim HS
Int J Clin Oncol; 2015 Dec; 20(6):1226-32. PubMed ID: 26123311
[TBL] [Abstract][Full Text] [Related]
16. Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery.
Ikoma N; Torres KE; Lin HY; Ravi V; Roland CL; Mann GN; Hunt KK; Cormier JN; Feig BW
J Surg Oncol; 2017 Sep; 116(3):313-319. PubMed ID: 28557016
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG
Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483
[TBL] [Abstract][Full Text] [Related]
18. [Leiomyosarcoma with prominent osteoclast-like giant cells: a clinicopathologic analysis of 7 cases and review of literature].
Li Y; Xu XL; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):363-7. PubMed ID: 21914342
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
Nicolas MM; Tamboli P; Gomez JA; Czerniak BA
Hum Pathol; 2010 May; 41(5):663-71. PubMed ID: 20004935
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
